BioLargo, Inc. (BLGO)
| Market Cap | 49.67M |
| Revenue (ttm) | 7.77M |
| Net Income (ttm) | -11.78M |
| Shares Out | 320.47M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,912 |
| Average Volume | 265,548 |
| Open | 0.152 |
| Previous Close | 0.150 |
| Day's Range | 0.147 - 0.155 |
| 52-Week Range | 0.138 - 0.258 |
| Beta | -0.11 |
| RSI | 50.34 |
| Earnings Date | May 15, 2026 |
About BioLargo
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company’s technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platf... [Read more]
Financial Performance
In 2025, BioLargo's revenue was $7.77 million, a decrease of -56.32% compared to the previous year's $17.78 million. Losses were -$11.78 million, 390.4% more than in 2024.
Financial StatementsNews
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
WESTMINSTER, CA / ACCESS Newswire / April 20, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that its engineering subsidi...
BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum
BioLargo sponsors legal and technical forum on PFAS contamination; company's PFAS remediation technology to be featured on a technical panel alongside leading environmental engineering firms, followed...
BioLargo Earnings Call Transcript: Q4 2025
2025 saw a revenue decline to $7.8M and a $15.2M net loss, mainly due to the Pooph license termination, but strong liquidity and service revenue growth were maintained. Clyra Medical entered commercialization, AEC achieved regulatory validation, and Cellinity Battery advanced joint ventures, positioning for a transformative 2026.
BioLargo Reports Annual 2025 Operating and Financial Results
A Year of Disciplined Execution as BioLargo Gained Commercialization for Several Business Segments with $3.9 Million Cash Balance at Year End WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 5, 2026 ...
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 4, 2026 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will h...
BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium
Clinical Experience Presented at Boswick Symposium Shows Rapid Wound Transformation, Enhanced Healing, and Strong Antimicrobial Performance Across Multiple Wound Types WESTMINSTER, CALIFORNIA / ACCESS...
BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution
Initial Distribution Launch Marks Transition to Revenue-Generating Operations WESTMINSTER, CALIFORNIA / ACCESS Newswire / February 9, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences ...
BioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New Jersey
WESTMINSTER, CALIFORNIA / ACCESS Newswire / January 27, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system has been ins...
BioLargo Transcript: Sidoti Micro-Cap Virtual Investor Conference
The presentation outlined a diversified portfolio of transformative technologies in battery storage, infection control, and PFAS remediation, each positioned for market leadership and monetization. Key assets are entering adoption and commercialization phases, with major partnerships, regulatory milestones, and financing events expected in the next six months.
BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST
WESTMINSTER, CA / ACCESS Newswire / January 16, 2026 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve challenging environmental and cleantech ...
BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation
WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 29, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that it had deliv...
BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough
Lake Stockholm, NJ AEC System Delivered and Preparing to Go Live WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 3, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainabl...
BioLargo to Present at NobleCon's 21st Annual Emerging Growth Equity Conference, Dec. 2-3, 2025
Westminster, California--(Newsfile Corp. - November 21, 2025) - BioLargo, Inc. (OTCQX: BLGO), a company that creates and commercializes sustainable technologies to solve challenging environmental and ...
BioLargo Reports Q3 2025 Operating and Financial Results
$4.5 Million Cash Balance at Quarter-End as High-Impact Technology Portfolio Advances WESTMINSTER, CALIFORNIA / ACCESS Newswire / November 17, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that create...
BioLargo Earnings Call Transcript: Q3 2025
Q3 results were impacted by a $3.85M Pooph credit loss, halving revenue year-over-year, but strong cash reserves and ongoing investment in CLYRA and battery tech position the company for future growth. PFAS and battery segments achieved technical milestones, with major commercialization steps expected soon.
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
WESTMINSTER, CA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host ...
BioLargo Subsidiary Clyra Medical Technologies Forms Strategic Alliance with Advanced Solution to Launch ViaCLYR(TM) Wound Irrigation Solution Nationwide
Distribution Agreement Brings Innovative Copper-Iodine Complex Technology to Wound Care Market WESTMINSTER, CALIFORNIA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech ...
BioLargo Files Federal Lawsuit Against Pooph Inc.
Nine-count complaint alleges fraud, false advertising, breach of contract, and patent infringement WESTMINSTER, CA / ACCESS Newswire / November 12, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech inno...
BioLargo Cuts AEC PFAS Treatment Energy Use by >90%, Unlocking Commercial-Scale Water Solutions with Unmatched Total Life Cycle Cost Savings
WESTMINSTER, CA / ACCESS Newswire / November 3, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that develops and commercializes sustainable technologies, today announced a breakthrough upgr...
BioLargo Presentation Deck at LD Micro Event Available Online
Cellinity battery cell technology, BioLargo's role in the global AI infrastructure investment cycle, and a general corporate update are featured in the presentation. WESTMINSTER, CA / ACCESS Newswire ...
BioLargo Transcript: LD Micro Main Event XIX Investor Conference
A diversified innovation portfolio is advancing in energy storage, medical tech, and environmental solutions, with major launches and global partnerships underway. The company is scaling battery factory licensing, addressing supply chain and safety gaps, and expects significant value realization as assets reach market adoption.
Biolargo Invites You to the Sustain SoCal 16th Annual Energy Event - A Premier Gathering for Clean Energy Innovation
WESTMINSTER, CA / ACCESS Newswire / October 14, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies is excited to invite professionals, i...
BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PT
Cellinity is a breakthrough battery storage solution for AI infrastructure that eliminates the need for rare earth elements WESTMINSTER, CA / ACCESS Newswire / October 14, 2025 / BioLargo, Inc. (OTCQX...
BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion
Initial Commercialization Targeting $732 Million Wound Care Market is Expected in Late 2025 or Early 2026 WESTMINSTER, CALIFORNIA / ACCESS Newswire / October 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a ...
BioLargo Protects Its Intellectual Property That Built a National Brand - Pooph's License Was Revoked for Non-Payment and Unauthorized Activities
WESTMINSTER, CA / ACCESS Newswire / October 7, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies, today reaffirmed its commitment to pr...